<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02833363</url>
  </required_header>
  <id_info>
    <org_study_id>2016SDU-QILU-08</org_study_id>
    <nct_id>NCT02833363</nct_id>
  </id_info>
  <brief_title>Difference of Gastric Microbiota in the Process of Correa's Model.</brief_title>
  <official_title>Difference of Gastric Microbiota in the Process of Correa's Model.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Helicobater pylori plays an important role in the development of gastric cancer. Eradication
      therapy can reducing the morbidity of gastric cancer, but can't totally prevent it especially
      when atrophy and more serious precancerous lesions already happened. Prior studies found the
      gastric bacterial difference among gastritis, intestinal metaplasia and gastric cancer.
      However, they didn't reach an agreement. Correa's model is widely accepted in the development
      of gastric cancer. The pathological change makes a more suitable environment for bacteria to
      overgrowth. This study are designed to analyze the gastric microbial difference of
      non-atrophic gastritis, atrophic gastritis, intestinal metaplasia, intraepithelial neoplasia
      and gastric cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference of Gastric Microbiota in the Process of Correa's Model.</measure>
    <time_frame>5 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference of Gastric Microbiota in the Process of Correa's Model.</measure>
    <time_frame>5 months</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Gastric Microbiota</condition>
  <condition>Non-atrophic Gastritis</condition>
  <condition>Atrophic Gastritis</condition>
  <condition>Intestinal Metaplasia</condition>
  <condition>Intraepithelial Neoplasia</condition>
  <condition>Gastric Cancer</condition>
  <condition>Helicobacter Pylori</condition>
  <arm_group>
    <arm_group_label>patients with non-atrophic gastritis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with gastritis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with intestinal metaplasia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with intrepithelial neoplasia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with non-cardia gastric cancer</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      gastric mucosal samples from antrum and corpus will be collected during gastroscopy,and used
      for microbiota analysis by high-throughput sequencing.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients go through a gastric endoscopy examination with non-atrophic gastritis, atrophic
        gastris, intestinal metaplasia, intraepithelial neoplasia and gastric cancer.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients go through a gastric endoscopy examination with non-atrophic gastritis,
             atrophic gastris, intestinal metaplasia, intraepithelial neoplasia and gastric cancer.

          2. Did not take any antibiotics,PPI,probiotics and chinese herbs in the past one
             month,and took less than one week in the past three months before the gastroscopy
             examination.

          3. Sign the informed consent.

        Exclusion Criteria:

          1. Had been taken Helicobacter pylori eradication therapy before.

          2. Previous gastrointestinal surgery.

          3. During the pregnancy and lactation period.

          4. With any serious diseases like liver failure,heart failure,renal failure,malignant
             tumor,alcoholism or any other disease that may effect the result.

          5. With any mental problems.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yanqing Li, MD,PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Qilu Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yanqing Li, MD,PHD</last_name>
    <phone>86-531-82169236</phone>
    <email>liyanqing@sdu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastroenterology, Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanqing Li, MD,PHD</last_name>
      <phone>86-531-82169236</phone>
      <phone_ext>82169508</phone_ext>
      <email>liyanqing@sdu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Yanqing Li, MD,PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tian Ma, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2016</study_first_submitted>
  <study_first_submitted_qc>July 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2016</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>Vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <keyword>gastric microbiota</keyword>
  <keyword>Helicobacter pylori</keyword>
  <keyword>Non-atrophic Gasrititis</keyword>
  <keyword>Atrophic gastritis</keyword>
  <keyword>Intestinal metaplasia</keyword>
  <keyword>intraepithelial neoplasia</keyword>
  <keyword>Gastric cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Metaplasia</mesh_term>
    <mesh_term>Gastritis, Atrophic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

